Navigation Links
U.S. Food and Drug Administration Clears Alcatel-Lucent Remote Patient Monitoring Solution for Sale in the United States
Date:11/4/2009

PARIS, Nov. 4 /PRNewswire/ -- Alcatel-Lucent (Euronext Paris and NYSE: ALU) today announced that the Alcatel-Lucent TeleHealth Manager, a secure and reliable remote patient monitoring solution, has been cleared by the U.S. Food and Drug Administration (FDA) for marketing in the United States.

The Alcatel-Lucent TeleHealth Manager supports remote patient monitoring with an easily deployable solution for standard mobile phones from leading vendors. It allows patients to provide health data using devices they're already familiar with (e.g., mobile phones and medical devices such as blood glucose meters) in a secure manner, without the expense, time and potential exposure to other diseases that unnecessary clinical visits might entail. In addition to monitoring, TeleHealth Manager provides reminders, alerts and online reports to help patients and their healthcare professionals better understand and manage their conditions.

Faced with challenges such as an aging population and rising healthcare costs, hospitals and physicians are increasingly turning to innovative communications technologies such as remote patient monitoring to supplement face-to-face care. Especially for patients with chronic diseases such as diabetes and hypertension, remote patient monitoring offers an efficient and accurate way for care providers to regularly gather potentially lifesaving data. While cost effective for health care systems and home care agencies, remote monitoring also offers convenience, cost savings and empowerment to patients -- and enables more informed treatment decisions that can result in improved outcomes.

"The Alcatel-Lucent TeleHealth Manager supports our focus to enable patient-centric healthcare through technology," said Tom Burns, head of Alcatel-Lucent's enterprise and verticals business. "With the FDA clearance to market this cutting-edge solution in the United States, clinicians and patients will be able to better work together to monitor and manage certain chronic diseases."

With the TeleHealth Manager solution, Alcatel-Lucent has taken advantage of its strong relationships with telecom service providers and healthcare organizations, and its global expertise in fixed and mobile telephony. The Alcatel-Lucent TeleHealth Manager requires minimal capital investment to deploy and can be hosted by a telecom service provider, a healthcare organization or offered as a managed service by Alcatel-Lucent.

Additional information about Alcatel-Lucent healthcare solutions is available online.

About Alcatel-Lucent

Alcatel-Lucent (Euronext Paris and NYSE: ALU) is the trusted partner of service providers, enterprises and governments worldwide, providing solutions to deliver voice, data and video communication services to end-users. A leader in fixed, mobile and converged broadband networking, IP technologies, applications and services, Alcatel-Lucent leverages the unrivalled technical and scientific expertise of Bell Labs, one of the largest innovation powerhouses in the communications industry. With operations in more than 130 countries and the most experienced global services organization in the industry, Alcatel-Lucent is a local partner with a global reach. Alcatel-Lucent achieved revenues of Euro 16.98 billion in 2008 and is incorporated in France, with executive offices located in Paris. For more information, visit Alcatel-Lucent on the Internet: http://www.alcatel-lucent.com

SOURCE Alcatel-Lucent


'/>"/>
SOURCE Alcatel-Lucent
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Caliper Life Sciences Presents LabChip(R) Platform to the U.S. Food and Drug Administration
2. Oramed Pharmaceuticals was Chosen to Present Results of a GLP-1 Analog Oral Administration Study at the Diabetes Technology Societys Ninth Annual Meeting (November 5-7, 2009; San Francisco, CA)
3. U.S. Food and Drug Administration Approves CRESTOR(R) for Use in Pediatric Patients With Heterozygous Familial Hypercholesterolemia
4. Food and Drug Administration Expert to Deliver Keynote Address
5. Chinese Food and Drug Administration Approves Gabexate Mesylate as Pharmaceutical Raw Material
6. Biostar Pharmaceuticals, Inc. Receives the Chinese Military Drug Administration Clearance to Begin Clinical Trial for Zushima Analgesic Aerosol Spray
7. United States Patent Office Allows Claims Covering the Approved Administration of Kuvan with Food
8. Regence to Cover Administration Costs of H1N1 Vaccine for Fully-Insured Groups, Individuals This Flu Season
9. Food and Drug Administration Accepts Isolagens Biologics License Application for Full Review
10. U.S. Food and Drug Administration Clears Way for Multi-Center Clinical Trial of IDEV Technologies SUPERA Peripheral Stent
11. Isolagen, Inc. Submits Biologics License Application for the Treatment of Wrinkles to the U.S. Food and Drug Administration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... Research and Markets has announced the addition of the "Hemophilia ... ... Drugs Price Analysis and Strategies - 2016, provides drug pricing data and ... questions: What are the key drugs marketed ... Global Hemophilia market? What are the unit prices and ...
(Date:2/24/2017)... , Feb. 24, 2017 Juan ... & Associates PC , a boutique securities firm headquartered ... York City , announces that a class action ... Massachusetts  against Inotek Pharmaceuticals Corporation (NASDAQ: ... the Company,s securities between July 23, 2015 and December 30, ...
(Date:2/24/2017)... Feb. 23, 2017  Directors from Pharma To Market Pty Ltd ... joined forces, resulting in the founding of Pharma To Market Pte ... To Market are pleased to announce their expansion into ... Singapore . The company are delighted to appoint ... the Singapore based entity. Joelle brings with ...
Breaking Medicine Technology:
(Date:2/27/2017)... (PRWEB) , ... February 27, 2017 , ... Elisa Guajardo Carothers is not your typical ... to studying to become a nun. Now, she writes about God, when she isn’t swimming ... Know BC and AD, Here is BS! (Before Satan),” she offers a comedic look at ...
(Date:2/27/2017)... N. Y. (PRWEB) , ... February 27, 2017 , ... ... ( ILADS ) has disclosed that despite scientific studies, the Center for Disease Control ... chronic Lyme disease . Kenneth B. Liegner, M.D. has compiled into a ...
(Date:2/27/2017)... ... February 27, 2017 , ... Silicon Valley Hair Institute, a ... an upgrade to the company's Yelp listing. Bay Area residents struggling from thinning ... as Platelet Rich Plasma (PRP) therapy, hair transplantation techniques such as Follicular Unit ...
(Date:2/26/2017)... ... February 26, 2017 , ... This is an extension of ... to be ISO/IEC 17025:2005 INAB accredited for Der p 1 (house dust mite ... globally recognised standard that sets out requirements for the technical competence of testing ...
(Date:2/26/2017)... (PRWEB) , ... February 26, ... ... sets a new technology standard in staffing, scheduling, and reporting for healthcare ... and predict activity throughout the entire staffing process. StaffBridge technology improves staffing ...
Breaking Medicine News(10 mins):